Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab

Regulatory roles of hyaluronan in health and disease

(2011) Vincent Hascall et al.   FEBS Journal

Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration

(2011) Kevin Zarrabi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

(2011) Benoit You et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Metalloproteinases in health and disease: challenges and the future prospects

(2010) Hideaki Nagase et al.   FEBS Journal

Proteoglycans in health and disease: emerging concepts and future directions

(2010) Renato V. Iozzo et al.   FEBS Journal

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

(2010) Marc Peeters et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

(2010) Jean-Yves Douillard et al.   JOURNAL OF CLINICAL ONCOLOGY

KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy

(2009) Ahmad D. Siddiqui et al.   ANNALS OF SURGICAL ONCOLOGY

Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies

(2009) Ch. Gialeli et al.   CURRENT MEDICINAL CHEMISTRY

Targeting focal adhesion kinase signaling in tumor growth and metastasis

(2009) Joerg Schwock et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab

(2008) M. Jhawer et al.   CANCER RESEARCH

Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer

(2008) Mei Wu et al.   CLINICAL THERAPEUTICS

Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

(2008) Rafael G. Amado et al.   JOURNAL OF CLINICAL ONCOLOGY